# leuprolide acetate

NDC: 0121-2106
Generic name: leuprolide acetate
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: KIT
Routes: SUBCUTANEOUS
Marketing started: 20250201

FDA application: ANDA217957

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-2106"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-2106
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=19be0b7f-e68a-4547-9e49-b51b12821907